NCT04945044

Brief Summary

The main purpose of the study to evaluate the usefulness of the Endo-AID artificial intelligence system in the detection of colorectal adenomas in consecutive patients for outpatient colonoscopy. The secondary aims were:

  • To evaluate the benefit of Endo-AID in adenoma detection rate by comparing endoscopists with high and low adenoma detection rate.
  • To evaluate serrated detection rate, advanced adenoma detection rate, adenoma detection rate according to the size (\<= 5mm, 6-9mm,\> = 10mm) and number of adenomas by colonoscopy. Stratification by location and morphology.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
370

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 30, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

November 15, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2022

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

3 months

First QC Date

June 22, 2021

Last Update Submit

September 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    Number of colonoscopies with colorectal adenoma/Number of total colonoscopies

    [Time frame: 1 years][Designated as safety issue: No]

Secondary Outcomes (2)

  • Serrated detection rate

    [Time Frame: 1 years][Designated as safety issue: No]

  • Advanced adenoma detection rate

    [Time Frame: 1 years][Designated as safety issue: No]

Study Arms (2)

Computed adenoma detection system (CADe)

EXPERIMENTAL

Tis system can detect in the screen suspicion areas of adenomatous polyps. This is an additional help for the endoscopist for the detection of lesions

Device: Computed adenoma detection system (CADe)

Control group (absence of CADe)

ACTIVE COMPARATOR

This is the control group. As in the routine colonoscopy the endoscopist is in charge of the detection of the lesions.

Behavioral: Control group (regular colonoscopy)

Interventions

This is a computed system that helps the endoscopist to increase the detection of colorectal polyps

Computed adenoma detection system (CADe)

It is exclusively the endoscopist in charge of the detection of the polyps (usual practice)

Control group (absence of CADe)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years.
  • Patients referred for outpatient colonoscopy

You may not qualify if:

  • Colonic resection
  • Taking anticoagulants or antiagregants that contraindicate the performance of therapy
  • Patients with a recent colonoscopy (\<6 months) of good quality (e.g. cited for endoscopic therapy)
  • Inflammatory bowel disease
  • Patients with incomplete colonoscopy
  • Patients with inadequate preparation using the Boston Colonic Preparation Scale (BBPS). A cleaning quality of less than 2 points in any of the 3 colonic sections will be considered inadequate.
  • Patients with polyposis syndromes
  • Refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Gastroenterology

San Cristóbal de La Laguna, S/C de Tenerife, 38320, Spain

Location

Related Publications (5)

  • Hassan C, Spadaccini M, Iannone A, Maselli R, Jovani M, Chandrasekar VT, Antonelli G, Yu H, Areia M, Dinis-Ribeiro M, Bhandari P, Sharma P, Rex DK, Rosch T, Wallace M, Repici A. Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis. Gastrointest Endosc. 2021 Jan;93(1):77-85.e6. doi: 10.1016/j.gie.2020.06.059. Epub 2020 Jun 26.

    PMID: 32598963BACKGROUND
  • Berzin TM, Parasa S, Wallace MB, Gross SA, Repici A, Sharma P. Position statement on priorities for artificial intelligence in GI endoscopy: a report by the ASGE Task Force. Gastrointest Endosc. 2020 Oct;92(4):951-959. doi: 10.1016/j.gie.2020.06.035. Epub 2020 Jun 19.

  • Wang P, Liu X, Berzin TM, Glissen Brown JR, Liu P, Zhou C, Lei L, Li L, Guo Z, Lei S, Xiong F, Wang H, Song Y, Pan Y, Zhou G. Effect of a deep-learning computer-aided detection system on adenoma detection during colonoscopy (CADe-DB trial): a double-blind randomised study. Lancet Gastroenterol Hepatol. 2020 Apr;5(4):343-351. doi: 10.1016/S2468-1253(19)30411-X. Epub 2020 Jan 22.

  • Wang P, Liu P, Glissen Brown JR, Berzin TM, Zhou G, Lei S, Liu X, Li L, Xiao X. Lower Adenoma Miss Rate of Computer-Aided Detection-Assisted Colonoscopy vs Routine White-Light Colonoscopy in a Prospective Tandem Study. Gastroenterology. 2020 Oct;159(4):1252-1261.e5. doi: 10.1053/j.gastro.2020.06.023. Epub 2020 Jun 17.

  • Gimeno-Garcia AZ, Hernandez Negrin D, Hernandez A, Nicolas-Perez D, Rodriguez E, Montesdeoca C, Alarcon O, Romero R, Baute Dorta JL, Cedres Y, Castillo RD, Jimenez A, Felipe V, Morales D, Ortega J, Reygosa C, Quintero E, Hernandez-Guerra M. Usefulness of a novel computer-aided detection system for colorectal neoplasia: a randomized controlled trial. Gastrointest Endosc. 2023 Mar;97(3):528-536.e1. doi: 10.1016/j.gie.2022.09.029. Epub 2022 Oct 11.

MeSH Terms

Interventions

Control Groups

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Antonio Gimeno Garcia, MD, PhD

    Hospital Universitario de Canarias

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2021

First Posted

June 30, 2021

Study Start

November 15, 2021

Primary Completion

January 31, 2022

Study Completion

January 31, 2022

Last Updated

September 21, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations